isomethyleugenol has been researched along with Ovarian Neoplasms in 76 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 3 (3.95) | 18.7374 |
1990's | 10 (13.16) | 18.2507 |
2000's | 15 (19.74) | 29.6817 |
2010's | 27 (35.53) | 24.3611 |
2020's | 21 (27.63) | 2.80 |
Authors | Studies |
---|---|
Bai, J; Chen, C; Liu, J; Qian, C; Wang, Y; Wei, J; Xing, Y | 1 |
Apanovich, NV; Braga, EA; Brovkina, OI; Burdennyy, AM; Dmitriev, AA; Filippova, EA; Fridman, MV; Karpukhin, AV; Kazubskaya, TP; Kushlinskii, NE; Loginov, VI; Lukina, SS; Pronina, IV; Stilidi, IS; Uroshlev, LA | 1 |
Chen, K; Chen, Y; Li, Y; Liao, N; Liu, J; Luo, M; Mo, Z; Wang, M; Xiao, J; Zeng, J; Zhang, Q; Zou, J | 1 |
Gao, Y; Tan, M; Xie, T; Yang, H | 1 |
Gao, J; Li, F; Tan, M; Wang, S; Xu, H; Zhu, L | 1 |
Chen, QH; Chen, YL; He, SL; Tian, Q; Yi, SJ | 1 |
Li, X; Wang, X; Wu, J | 1 |
Xing, J; Yin, X; Zhang, M; Zhao, S; Zhou, J; Zhu, X | 1 |
Chan, JY; Chen, J; Deng, P; Guan, P; Hong, JH; Huang, Y; Liu, L; Liu, S; Ong, CK; Sun, Y; Tan, J; Teh, BT; Wang, P; Wang, Y; Wen, S; Xiao, R; Xiong, Y; Yin, J; Yu, Q; Yu, Z; Zeng, X | 1 |
Hong, L; Wang, S; Wang, X; Zheng, L; Zhu, G | 1 |
Guan, W; Li, X; Liu, H; Wang, F; Xu, G; Yuan, J | 1 |
Chen, L; Chen, Q; Gao, W; Li, T; Li, Y; Lin, L; Long, L; Sha, C; Wei, H; Xing, J; Xu, W; Yang, M; Zhang, M; Zhao, S; Zhu, X | 1 |
Chen, X; Ji, H; Jiang, M; Liu, H; Liu, Y; Song, G; Wang, ZW; Ye, M; Zhu, X | 1 |
Czogalla, B; Han, N; Hester, A; Jeschke, U; Kuhn, C; Mahner, S; Mayr, D; Rottmann, M; Schmoeckel, E; Trillsch, F | 1 |
Cardenas, H; Chaparala, A; Chen, J; Davuluri, RV; Huang, H; Ji, Y; Kandpal, M; Matei, D; Tanner, EJ; Wang, Y; Zhao, G | 1 |
Li, Q; Wang, Q; Zhang, J; Zhang, Q | 1 |
An, N; Chen, XJ | 1 |
Choi, YJ; Hur, S; Jung, Y; Kang, BS; Kim, M; Lee, S; Liu, J | 1 |
Dai, ZY; Fang, JD; Jin, SM; Leng, HL; Luo, HQ | 1 |
Kwon, JS | 1 |
Guan, Q; Guo, H; Hong, D; Ji, J; Liu, J; Ren, Q; Zhang, C; Zhang, Q | 1 |
Dobrovic, A | 1 |
Alejo, S; Hoang, N; Khal, A; Lee, L; Leng, F; Lu, F; Qi, D; Saxena, L; Sun, H; Zhang, C; Zhang, H | 1 |
Dvorakova, P; Hernychova, L; Nenutil, R; Novotny, MV; Rehulka, P; Rehulkova, H; Valik, D; Vojtesek, B; Zahradnikova, M | 1 |
Cai, J; Guo, J; Huang, Z; Liu, T; Tang, G; Wang, Z; Yu, L; Zhu, Y | 1 |
Braga, EA; Burdennyy, AM; Dmitriev, AA; Filippova, EA; Kazubskaya, TP; Khodyrev, DS; Kushlinskii, NE; Kushlinsky, DN; Loginov, VI; Pronina, IV; Utkin, DO | 1 |
Cao, CH; Chen, G; Feng, XX; Feng, ZH; Gao, QL; Li, MC; Liu, D; Ma, D; Tan, JH; Wan, DY; Wang, H; Wang, J; Wu, P; Xi, BX; Xi, L; Yang, ZY; Ye, F; Zhang, XX; Zhou, JF | 1 |
Arend, RC; Jones, BA; Varambally, S | 1 |
Huang, S; Lau, B; Lau, WB; Tang, K; Wang, H; Wang, W; Wang, X; Wei, Y; Xu, L; Yang, Q; Yang, Y; Yang, Z; Yi, T; Zhao, L; Zhao, X; Zhou, N; Zhou, S | 1 |
Lan, R; Li, S; Lu, F; Ma, Y; Wang, Q; Yu, M; Zhang, H; Zhang, X | 1 |
Anderson, WF; Anglesio, MS; Bodelon, C; Bowtell, DDL; Brinton, LA; Doherty, JA; Killian, JK; Lissowska, J; Matsuno, R; Ramus, SJ; Sampson, JN; Sherman, ME; Talhouk, A; Wentzensen, N | 1 |
Bachvarov, D; Bachvarova, M; Gregoire, J; Keita, M; Morin, C; Plante, M; Renaud, MC; Sebastianelli, A; Trinh, XB | 1 |
Falahi, F; Hospers, GA; Huisman, C; Kazemier, HG; Kok, K; Rots, MG; van der Vlies, P | 1 |
Berger, M; Blanchard, V; Braicu, EI; Ehlers, M; Hoppe, B; Kaup, M; Petzold, D; Schwedler, C; Sehouli, J; Tauber, R | 1 |
Costa, SD; Eggemann, H; Ignatov, A; Ignatov, T; Kalinski, T; Roessner, A | 1 |
Chen, J; Fu, Y; Li, C; Pang, B; Shen, K; Zhao, J | 1 |
Cao, JM; Chen, NN; Li, CY; Li, D; Sun, WP; Wang, XX; Zhou, YM | 1 |
Jin, P; Li, N; Zhang, C | 1 |
Blanco-González, E; Cinti, M; Fernández de la Campa, MR; Iglesias González, T; Montes-Bayón, M | 1 |
Cheng, X; Li, X; Lu, W; Mao, Y; Pan, Q; Wan, X; Xie, X | 1 |
Davidson, B; Falnes, PØ; Jakobsson, ME; Moen, A | 1 |
Kitanaka, C; Kurachi, H; Kuramoto, K; Nagase, S; Ohta, T; Okada, M; Sakaki, H; Seino, M; Seino, S; Suzuki, S; Takeda, H; Watarai, H | 1 |
Cardenas, H; Matei, D; Nephew, KP; Vieth, E; Zhao, J | 1 |
Czekierdowska, S; Czekierdowski, A; Czuba, B; Danilos, J; Kotarski, J; Sodowska, H; Sodowski, K; Szymanski, M | 1 |
Cai, J; Hu, S; Li, Z; Shen, Y; Wang, J; Wang, Z; Xiao, L; Yu, L | 1 |
Blanco-Fernández, A; Dempsey, E; Harvey, DJ; Madden, SF; Mariño, K; McCann, A; Peracaula, R; Pérez-Garay, M; Rudd, PM; Saldova, R; Struwe, WB; Watson, JA | 1 |
Alley, WR; Goetz, JA; Hussein, A; Mann, BF; Matei, DE; Mechref, Y; Menning, N; Novotny, MV; Svoboda, M; Vasseur, JA | 1 |
Lee, C; Lee, HS | 1 |
Chang, MC; Chen, CA; Chen, PJ; Cheng, WF; Chiang, YC; Hsieh, CY; Wu, MM | 1 |
Andriantsiferana, R; Chaturvedula, VS; Kingston, DG; Miller, JS; Rasamison, VE; Schilling, JK | 1 |
Burrows, JF; Chanduloy, S; Donaghy, P; Godwin, AK; Johnston, PG; McIlhatton, MA; Nagar, H; Price, J; Russell, SE; Yeates, K | 1 |
Amada, S; Furuya, T; Hirakawa, T; Kawasaki, K; Kawauchi, S; Liu, XP; Oga, A; Sasaki, K | 1 |
Horiuchi, A; Konishi, I | 2 |
Gaiger, A; Grunt, TW; Kainz, B; Puckmair, K; Tomek, K | 1 |
Baudler, M; Beck, JF; Benimetskaya, L; Gekeler, V; Gimmnich, P; Gonser, B; Grebe, C; Hanauer, G; Hofmann, HP; Leja, A; Maier, T; Pieles, U; Römmele, M; Sanders, K; Stein, CA; Wagner, T | 1 |
Capo-chichi, CD; Caslini, C; Nicolas, E; Roland, IH; Xu, XX; Yeung, AT | 1 |
Case, EA; Conway, PS; Gallion, HH; Pieretti, M; Powell, DE; Turker, MS | 1 |
Mann, M; Varmuza, S | 1 |
Carcangiu, ML; Han, H; Li, S; Resnik, E; Schwartz, PE; Yang-Feng, TL | 1 |
Baranowski, W; Keith, G; Tomaszewski, J | 1 |
Crenshaw, T; Hao, Y; Moulton, T; Shields, T; Tycko, B; Zhang, Y | 1 |
Driscoll, DJ; Locker, J; Mowery-Rushton, PA; Nicholls, RD; Surti, U | 1 |
Götzinger, N; Mueller-Lantzsch, N; Roemer, K; Sauter, M | 1 |
Boiocchi, M; Corona, G; Donada, C; Fabris, M; Toffoli, G; Viel, A; Zarrelli, A | 1 |
Buekers, T; Buller, RE; Lallas, T; Skilling, JS; Sood, AK | 1 |
Boyd, J; Narod, SA | 1 |
Fearon, ER | 1 |
Baylin, SB; Bonilla, F; Bussaglia, E; Dominguez, G; Esteller, M; Gabrielson, E; Harkes, IC; Herman, JG; Lerma, E; Matias-Guiu, X; Prat, J; Repasky, EA; Schutte, M; Silva, JM | 1 |
Chen, CL; Cheng, D; Ip, SM; Ngan, HY; Wong, LC | 1 |
Abdul-Karim, FW; Cheng, L; Eble, JN; Gu, J; Michael, H; Roth, LM; Ulbright, TM; Younger, C; Zhang, S | 1 |
Agoulnik, A; Arlt, K; Diatchenko, L; Dietel, M; Schäfer, R; Scharff, KM; Schober, H; Sers, C; Siebert, PD; Wiechen, K; Zhumabayeva, B | 1 |
Arnold, JM; Chenevix-Trench, G; Cummings, M; Purdie, D | 1 |
Dell, A; Fukuda, M; Fukuda, MN; Oates, JE | 1 |
Lu, T; Nelson, JH; Sheid, B | 1 |
Pillinger, DJ; Wilkinson, R | 1 |
5 review(s) available for isomethyleugenol and Ovarian Neoplasms
Article | Year |
---|---|
The potential regulatory role of RNA methylation in ovarian cancer.
Topics: Epigenesis, Genetic; Female; Humans; Methylation; Ovarian Neoplasms; RNA | 2023 |
Histone Methyltransferase EZH2: A Therapeutic Target for Ovarian Cancer.
Topics: Enhancer of Zeste Homolog 2 Protein; Female; Gene Expression Regulation, Neoplastic; Histones; Humans; Lysine; Methylation; Molecular Targeted Therapy; Ovarian Neoplasms; Small Molecule Libraries | 2018 |
Epigenetics in ovarian cancer: premise, properties, and perspectives.
Topics: Acetylation; Epigenesis, Genetic; Female; Gene Expression Regulation, Neoplastic; Histone Acetyltransferases; Histone Deacetylases; Histone Demethylases; Histones; Humans; Methylation; Ovarian Neoplasms | 2018 |
[Mechanism of ovarian cancer metastasis--changes in E-cadherin expression].
Topics: Cadherins; Cell Adhesion; Female; Gene Expression Regulation, Neoplastic; Humans; Hypoxia; Hypoxia-Inducible Factor 1, alpha Subunit; Methylation; Neoplasm Metastasis; Ovarian Neoplasms; Promoter Regions, Genetic; Transcription Factors | 2004 |
[Prevention of ovarian cancer development].
Topics: Alleles; Asbestos; Clomiphene; Diet; Female; Fertility Agents, Female; Genes, BRCA1; Gonadotropins; Humans; Life Style; Loss of Heterozygosity; Methylation; Obesity; Ovarian Neoplasms; Ovulation; Promoter Regions, Genetic; Risk Factors; Talc | 2004 |
71 other study(ies) available for isomethyleugenol and Ovarian Neoplasms
Article | Year |
---|---|
Comprehensive of N1-Methyladenosine Modifications Patterns and Immunological Characteristics in Ovarian Cancer.
Topics: Adenosine; Carcinoma, Ovarian Epithelial; Female; Humans; Methylation; Ovarian Neoplasms; RNA Processing, Post-Transcriptional; Tumor Microenvironment | 2021 |
Aberrant Methylation of 20 miRNA Genes Specifically Involved in Various Steps of Ovarian Carcinoma Spread: From Primary Tumors to Peritoneal Macroscopic Metastases.
Topics: Carcinoma; Carcinoma, Ovarian Epithelial; Female; Gene Expression; Gene Expression Regulation, Neoplastic; Humans; Machine Learning; Methylation; MicroRNAs; Neoplasm Metastasis; Neoplasm Recurrence, Local; Neoplasm Staging; Ovarian Neoplasms; Peritoneum; Prognosis; Recurrence; Transcriptome | 2022 |
Identification of key genes associated with polycystic ovary syndrome (PCOS) and ovarian cancer using an integrated bioinformatics analysis.
Topics: Cell Adhesion Molecules; Cell Line, Tumor; Chemokine CXCL11; Computational Biology; Dendritic Cells; Disease Progression; Drug Resistance, Neoplasm; Female; Ferroptosis; Humans; Intercellular Signaling Peptides and Proteins; Interferon Regulatory Factors; Membrane Glycoproteins; Methylation; N-Acetylgalactosaminyltransferases; Nerve Tissue Proteins; Neutrophils; Nuclear Receptor Subfamily 4, Group A, Member 1; Ovarian Neoplasms; Polycystic Ovary Syndrome; Polypeptide N-acetylgalactosaminyltransferase; Prognosis; Receptor-Like Protein Tyrosine Phosphatases, Class 2; Receptors, FSH; Receptors, Interleukin; Receptors, Lysophosphatidic Acid; RNA, Messenger; STAT1 Transcription Factor; Transcriptome; Ubiquitin-Protein Ligases | 2022 |
CRABP2 accelerates epithelial mesenchymal transition in serous ovarian cancer cells by promoting TRIM16 methylation via upregulating EZH2 expression.
Topics: Apoptosis; Cell Line, Tumor; Cell Movement; Cell Proliferation; Enhancer of Zeste Homolog 2 Protein; Epithelial-Mesenchymal Transition; Female; Gene Expression Regulation, Neoplastic; Humans; Methylation; Ovarian Neoplasms; Receptors, Retinoic Acid; Tripartite Motif Proteins; Ubiquitin-Protein Ligases | 2022 |
A methylation-driven genes prognostic signature and the immune microenvironment in epithelial ovarian cancer.
Topics: Carcinoma, Ovarian Epithelial; Female; Gene Expression Regulation, Neoplastic; Humans; Methylation; Ovarian Neoplasms; Prognosis; Tumor Microenvironment | 2022 |
LncRNA KCNQ1OT1 promotes the metastasis of ovarian cancer by increasing the methylation of EIF2B5 promoter.
Topics: Carcinoma, Ovarian Epithelial; Eukaryotic Initiation Factor-2B; Female; Humans; Methylation; Methyltransferases; MicroRNAs; Neoplastic Processes; Ovarian Neoplasms; Potassium Channels, Voltage-Gated; Promoter Regions, Genetic; RNA, Long Noncoding | 2022 |
N6-methyladenosine methylation regulator FTO promotes oxidative stress and induces cell apoptosis in ovarian cancer.
Topics: Adenosine; Alpha-Ketoglutarate-Dependent Dioxygenase FTO; Animals; Apoptosis; Female; Humans; Methylation; Mice; Mice, Nude; Ovarian Neoplasms; Oxidative Stress | 2022 |
EZH2 mediated metabolic rewiring promotes tumor growth independently of histone methyltransferase activity in ovarian cancer.
Topics: Cell Line, Tumor; Enhancer of Zeste Homolog 2 Protein; Female; Histones; Humans; Methylation; Ovarian Neoplasms; Polycomb Repressive Complex 2 | 2023 |
Tumor-associated macrophages promote cisplatin resistance in ovarian cancer cells by enhancing WTAP-mediated N6-methyladenosine RNA methylation via the CXCL16/CXCR6 axis.
Topics: Cell Cycle Proteins; Cell Line, Tumor; Cell Proliferation; Cisplatin; Drug Resistance, Neoplasm; Female; Humans; Methylation; Ovarian Neoplasms; Receptors, CXCR6; RNA; RNA Splicing Factors; Tumor-Associated Macrophages | 2023 |
RBM15‑mediating MDR1 mRNA m
Topics: Female; Humans; Methylation; Ovarian Neoplasms; Paclitaxel; RNA; RNA-Binding Proteins; RNA, Messenger; Signal Transduction | 2023 |
A methylation- and immune-related lncRNA signature to predict ovarian cancer outcome and uncover mechanisms of chemoresistance.
Topics: Alpha-Ketoglutarate-Dependent Dioxygenase FTO; CD8-Positive T-Lymphocytes; Drug Resistance, Neoplasm; Female; Humans; Methylation; Ovarian Neoplasms; RNA, Long Noncoding | 2023 |
Methylation of BRD4 by PRMT1 regulates BRD4 phosphorylation and promotes ovarian cancer invasion.
Topics: Arginine; Cell Cycle Proteins; Female; Humans; Jumonji Domain-Containing Histone Demethylases; Methylation; Methyltransferases; Nuclear Proteins; Ovarian Neoplasms; Phosphorylation; Pregnancy; Protein Processing, Post-Translational; Protein-Arginine N-Methyltransferases; Repressor Proteins; Transcription Factors | 2023 |
H3K4me3 Is a Potential Mediator for Antiproliferative Effects of Calcitriol (1α,25(OH)2D3) in Ovarian Cancer Biology.
Topics: Adult; Aged; Aged, 80 and over; Calcitriol; Cell Line, Tumor; Cell Proliferation; Epigenesis, Genetic; Female; Histones; Humans; Kaplan-Meier Estimate; Lysine; Methylation; Middle Aged; Multivariate Analysis; Ovarian Neoplasms; Proportional Hazards Models; Receptors, Calcitriol; Survival Analysis | 2020 |
FTO-Dependent
Topics: 3' Untranslated Regions; Adenosine; AlkB Homolog 5, RNA Demethylase; Alpha-Ketoglutarate-Dependent Dioxygenase FTO; Alternative Splicing; Animals; Ascites; Carcinogenesis; Cell Line, Tumor; Cyclic AMP; Cyclic Nucleotide Phosphodiesterases, Type 1; Cyclic Nucleotide Phosphodiesterases, Type 4; Down-Regulation; Fallopian Tubes; Female; Gene Knockdown Techniques; Heterografts; Humans; Methylation; Mice; Mice, Inbred BALB C; Mice, Nude; Neoplastic Stem Cells; Ovarian Neoplasms; Ovary; RNA Stability; RNA, Messenger; Second Messenger Systems; Sequence Analysis, RNA; Spheroids, Cellular; Tissue Array Analysis; Transcriptome; Tumor Suppressor Proteins | 2020 |
Clinicopathological and immunological characterization of RNA m
Topics: Adenosine; Biomarkers, Tumor; Female; Gene Expression Regulation, Neoplastic; Humans; Methylation; Nerve Tissue Proteins; Nuclear Proteins; Ovarian Neoplasms; RNA Processing, Post-Transcriptional; RNA Splicing Factors; RNA-Binding Proteins | 2021 |
Long noncoding RNA ATB promotes ovarian cancer tumorigenesis by mediating histone H3 lysine 27 trimethylation through binding to EZH2.
Topics: Carcinogenesis; Cell Line, Tumor; Cell Movement; Cell Proliferation; Enhancer of Zeste Homolog 2 Protein; Female; Gene Expression Regulation, Neoplastic; Gene Silencing; Histones; Humans; Lysine; Methylation; Models, Biological; Neoplasm Invasiveness; Ovarian Neoplasms; Protein Binding; RNA, Long Noncoding; Treatment Outcome | 2021 |
Peripheral blood
Topics: BRCA1 Protein; BRCA2 Protein; Carcinoma, Ovarian Epithelial; Female; Genetic Predisposition to Disease; Germ-Line Mutation; Humans; Methylation; Ovarian Neoplasms | 2021 |
LncRNA HOTAIR regulates anoikis-resistance capacity and spheroid formation of ovarian cancer cells by recruiting EZH2 and influencing H3K27 methylation.
Topics: Anoikis; Cell Line, Tumor; Enhancer of Zeste Homolog 2 Protein; Female; Gene Expression Regulation, Neoplastic; Humans; Methylation; Ovarian Neoplasms; RNA, Long Noncoding | 2021 |
Comments on: Peripheral blood
Topics: BRCA1 Protein; Female; Humans; Methylation; Ovarian Neoplasms | 2021 |
m6A RNA methylation regulators were associated with the malignancy and prognosis of ovarian cancer.
Topics: Adenosine; Databases, Genetic; Female; Gene Regulatory Networks; Humans; Methylation; Neoplasm Invasiveness; Ovarian Neoplasms; Prognosis; RNA; Transcriptome | 2021 |
White Blood Cell BRCA1 Promoter Methylation Status and Ovarian Cancer Risk: A Perspective.
Topics: Female; Humans; Leukocytes; Methylation; Ovarian Neoplasms; Promoter Regions, Genetic | 2018 |
LSD1 demethylase and the methyl-binding protein PHF20L1 prevent SET7 methyltransferase-dependent proteolysis of the stem-cell protein SOX2.
Topics: Amino Acid Substitution; Animals; Cell Line, Tumor; Cells, Cultured; Chromosomal Proteins, Non-Histone; Embryonic Stem Cells; Female; HEK293 Cells; Histone Demethylases; Histone-Lysine N-Methyltransferase; Humans; Methylation; Mice, Inbred C57BL; Mutation; Neoplasm Proteins; Ovarian Neoplasms; Protein Processing, Post-Translational; Protein Stability; Proteolysis; Recombinant Fusion Proteins; RNA Interference; SOXB1 Transcription Factors; Teratocarcinoma | 2018 |
Microgradient separation technique for purification and fractionation of permethylated N-glycans before mass spectrometric analyses.
Topics: Biomarkers, Tumor; Chemical Fractionation; Chromatography; Chromatography, Liquid; Female; Healthy Volunteers; Humans; Methylation; Ovarian Neoplasms; Polysaccharides; Spectrometry, Mass, Electrospray Ionization; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 2018 |
Metformin inhibits ovarian cancer via decreasing H3K27 trimethylation.
Topics: AMP-Activated Protein Kinase Kinases; Cell Line, Tumor; Cell Movement; Cell Proliferation; Cell Survival; Epigenesis, Genetic; Female; Histones; Humans; Metformin; Methylation; Ovarian Neoplasms; Phosphorylation; Polycomb Repressive Complex 2; Protein Kinases | 2018 |
Novel miRNA genes deregulated by aberrant methylation in ovarian carcinoma are involved in metastasis.
Topics: Biomarkers, Tumor; Carcinoma, Ovarian Epithelial; CpG Islands; DNA Methylation; Down-Regulation; Epigenesis, Genetic; Female; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Histology; Humans; Methylation; MicroRNAs; Neoplasm Metastasis; Neoplasms, Glandular and Epithelial; Ovarian Neoplasms; Promoter Regions, Genetic; Up-Regulation | 2018 |
C/EBPβ enhances platinum resistance of ovarian cancer cells by reprogramming H3K79 methylation.
Topics: Antineoplastic Agents; Biomarkers, Tumor; CCAAT-Enhancer-Binding Protein-beta; Cell Line, Tumor; Chromatin; Cisplatin; Databases, Factual; DNA-Binding Proteins; Drug Resistance, Neoplasm; Epigenesis, Genetic; Epithelial Cells; Female; GATA1 Transcription Factor; GATA4 Transcription Factor; Histone-Lysine N-Methyltransferase; Histones; Humans; Interferon Regulatory Factor-3; Methylation; Methyltransferases; Nuclear Proteins; Ovarian Neoplasms; Primary Cell Culture; Prognosis; Survival Analysis; Transcription Factors | 2018 |
PHF20L1 antagonizes SOX2 proteolysis triggered by the MLL1/WDR5 complexes.
Topics: Animals; Cell Line, Tumor; Chromosomal Proteins, Non-Histone; Female; HEK293 Cells; Histone-Lysine N-Methyltransferase; Humans; Intracellular Signaling Peptides and Proteins; Methylation; Mice, Inbred NOD; Mice, SCID; Myeloid-Lymphoid Leukemia Protein; Ovarian Neoplasms; Protein Stability; Proteolysis; SOXB1 Transcription Factors; Teratoma; Ubiquitination | 2018 |
Molecular Classification of Epithelial Ovarian Cancer Based on Methylation Profiling: Evidence for Survival Heterogeneity.
Topics: Carcinoma, Ovarian Epithelial; DNA Copy Number Variations; Female; Gene Expression Regulation, Neoplastic; Humans; Methylation; Ovarian Neoplasms | 2019 |
The RUNX1 transcription factor is expressed in serous epithelial ovarian carcinoma and contributes to cell proliferation, migration and invasion.
Topics: Carcinoma, Ovarian Epithelial; Cell Line, Tumor; Cell Movement; Cell Proliferation; Core Binding Factor Alpha 2 Subunit; Female; G1 Phase Cell Cycle Checkpoints; Gene Expression Profiling; Humans; Methylation; Neoplasm Invasiveness; Neoplasm Metastasis; Neoplasms, Glandular and Epithelial; Ovarian Neoplasms; RNA Interference; RNA, Small Interfering | 2013 |
Towards sustained silencing of HER2/neu in cancer by epigenetic editing.
Topics: Breast Neoplasms; Cell Line, Tumor; DNA-Binding Proteins; Down-Regulation; Epigenesis, Genetic; Female; Gene Expression Regulation, Neoplastic; Gene Silencing; HEK293 Cells; Histone Methyltransferases; Histone-Lysine N-Methyltransferase; Humans; MCF-7 Cells; Methylation; Ovarian Neoplasms; Promoter Regions, Genetic; Receptor, ErbB-2; Transcription Factors | 2013 |
Sialic acid methylation refines capillary electrophoresis laser-induced fluorescence analyses of immunoglobulin G N-glycans of ovarian cancer patients.
Topics: Case-Control Studies; Electrophoresis, Capillary; Female; Humans; Immunoglobulin G; Methylation; N-Acetylneuraminic Acid; Ovarian Neoplasms; Polysaccharides | 2014 |
BRCA1 promoter methylation is a marker of better response to platinum-taxane-based therapy in sporadic epithelial ovarian cancer.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; BRCA1 Protein; Bridged-Ring Compounds; Carcinoma, Ovarian Epithelial; Disease-Free Survival; Female; Humans; Methylation; Middle Aged; Neoplasms, Glandular and Epithelial; Organoplatinum Compounds; Ovarian Neoplasms; Prognosis; Promoter Regions, Genetic; Taxoids; Young Adult | 2014 |
EZH2-induced H3K27me3 is associated with epigenetic repression of the ARHI tumor-suppressor gene in ovarian cancer.
Topics: Adenosine; Carcinogenesis; Carcinoma, Ovarian Epithelial; Cell Line, Tumor; Cell Proliferation; Enhancer of Zeste Homolog 2 Protein; Epigenetic Repression; Female; Gene Knockdown Techniques; Histones; Humans; Lysine; Methylation; Neoplasms, Glandular and Epithelial; Ovarian Neoplasms; Polycomb Repressive Complex 2; rho GTP-Binding Proteins; RNA, Small Interfering; Survival Analysis; Tumor Suppressor Proteins | 2015 |
BRCA1 as a nicotinamide adenine dinucleotide (NAD)-dependent metabolic switch in ovarian cancer.
Topics: BRCA1 Protein; BRCA2 Protein; Cell Line, Tumor; Cytokines; Female; Gene Knockdown Techniques; Humans; Methylation; Mutation; NAD; Nicotinamide Phosphoribosyltransferase; Ovarian Neoplasms; Promoter Regions, Genetic | 2014 |
Berberine exhibits antitumor effects in human ovarian cancer cells.
Topics: Adaptor Proteins, Signal Transducing; Antineoplastic Agents; Apoptosis; Berberine; Cell Line, Tumor; Cell Proliferation; Cisplatin; CpG Islands; Drug Synergism; Female; Humans; Inhibitor of Apoptosis Proteins; Methylation; MutL Protein Homolog 1; Nuclear Proteins; Ovarian Neoplasms; Promoter Regions, Genetic; Proto-Oncogene Proteins c-bcl-2; Survivin | 2015 |
Reversed phase and cation exchange liquid chromatography with spectrophotometric and elemental/molecular mass spectrometric detection for S-adenosyl methionine/S-adenosyl homocysteine ratios as methylation index in cell cultures of ovarian cancer.
Topics: Antineoplastic Agents; Cell Line, Tumor; Chromatography, High Pressure Liquid; Chromatography, Ion Exchange; Chromatography, Reverse-Phase; Cisplatin; DNA Methylation; Drug Resistance, Neoplasm; Female; Homocysteine; Humans; Methylation; Molecular Weight; Ovarian Neoplasms; S-Adenosylhomocysteine; S-Adenosylmethionine; Spectrometry, Mass, Electrospray Ionization; Tandem Mass Spectrometry | 2015 |
Methylation-associated Has-miR-9 deregulation in paclitaxel- resistant epithelial ovarian carcinoma.
Topics: Antineoplastic Agents, Phytogenic; Carcinoma, Ovarian Epithelial; Cell Line, Tumor; Cyclin G1; DNA Methylation; Down-Regulation; Drug Resistance, Neoplasm; Female; Gene Expression Regulation, Neoplastic; Genetic Loci; Humans; Methylation; MicroRNAs; Neoplasms, Glandular and Epithelial; Ovarian Neoplasms; Paclitaxel; Prognosis; RNA Interference; RNA, Messenger | 2015 |
Hsp70 (HSPA1) Lysine Methylation Status as a Potential Prognostic Factor in Metastatic High-Grade Serous Carcinoma.
Topics: Adult; Aged; Aged, 80 and over; Biomarkers, Tumor; Breast Neoplasms; Female; HSP70 Heat-Shock Proteins; Humans; Kaplan-Meier Estimate; Lysine; Methylation; Middle Aged; Neoplasm Grading; Neoplasms, Cystic, Mucinous, and Serous; Ovarian Neoplasms; Prognosis; Proportional Hazards Models; Protein Processing, Post-Translational | 2015 |
GSKJ4, A Selective Jumonji H3K27 Demethylase Inhibitor, Effectively Targets Ovarian Cancer Stem Cells.
Topics: Animals; Cell Differentiation; Cell Transformation, Neoplastic; Disease Models, Animal; Female; Humans; Jumonji Domain-Containing Histone Demethylases; Methylation; Mice; Mice, Inbred BALB C; Neoplastic Stem Cells; Ovarian Neoplasms; Xenograft Model Antitumor Assays | 2015 |
EZH2 inhibition promotes epithelial-to-mesenchymal transition in ovarian cancer cells.
Topics: Cell Line, Tumor; Enhancer of Zeste Homolog 2 Protein; Epithelial-Mesenchymal Transition; Female; Gene Expression Regulation, Neoplastic; Histones; Humans; Indoles; Methylation; Ovarian Neoplasms; Promoter Regions, Genetic; Protein Binding; Pyridones; RNA Interference; Transforming Growth Factor beta; Zinc Finger E-box Binding Homeobox 2 | 2016 |
Microvessel density and CpG island methylation of the THBS2 gene in malignant ovarian tumors.
Topics: Antigens, CD34; CpG Islands; Female; Gene Expression Regulation, Neoplastic; Humans; Methylation; Microvessels; Neoplasm Staging; Neovascularization, Pathologic; Ovarian Neoplasms; Ovary; Promoter Regions, Genetic; Reverse Transcriptase Polymerase Chain Reaction; Thrombospondins | 2008 |
Overexpression of EZH2 contributes to acquired cisplatin resistance in ovarian cancer cells in vitro and in vivo.
Topics: Animals; Antineoplastic Agents; Blotting, Western; Cell Line, Tumor; Cell Survival; Cisplatin; DNA-Binding Proteins; Dose-Response Relationship, Drug; Drug Resistance, Neoplasm; Enhancer of Zeste Homolog 2 Protein; Female; Gene Expression Regulation, Neoplastic; Histones; Humans; Lysine; Methylation; Mice; Mice, Inbred BALB C; Mice, Nude; Ovarian Neoplasms; Polycomb Repressive Complex 2; Reverse Transcriptase Polymerase Chain Reaction; RNA Interference; Transcription Factors; Tumor Burden; Xenograft Model Antitumor Assays | 2010 |
5-AZA-2'-deoxycytidine induced demethylation influences N-glycosylation of secreted glycoproteins in ovarian cancer.
Topics: Azacitidine; Carcinoma, Ovarian Epithelial; Decitabine; Female; Glycoproteins; Glycosylation; Glycosyltransferases; Humans; Methylation; Neoplasms, Glandular and Epithelial; Ovarian Neoplasms; Polysaccharides | 2011 |
N-linked glycan structures and their expressions change in the blood sera of ovarian cancer patients.
Topics: Antineoplastic Combined Chemotherapy Protocols; Benzamides; Biomarkers, Tumor; Carbohydrate Sequence; Case-Control Studies; Docetaxel; Female; Fucose; Glycomics; Humans; Imatinib Mesylate; Immunoglobulin G; Methylation; Ovarian Neoplasms; Piperazines; Polysaccharides; Pyrimidines; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization; Taxoids | 2012 |
Structural analysis of a new cytotoxic demethylated analogue of neo-N-methylsansalvamide with a different peptide sequence produced by Fusarium solani isolated from potato.
Topics: Amino Acid Sequence; Antineoplastic Agents; Cell Division; Cell Line, Tumor; Depsipeptides; Female; Fusarium; Humans; Lung Neoplasms; Magnetic Resonance Spectroscopy; Melanoma; Methylation; Molecular Structure; Ovarian Neoplasms; Peptides, Cyclic; Solanum tuberosum; Spectrometry, Mass, Electrospray Ionization; Uterine Neoplasms | 2012 |
Epigenetic silencing of BLU through interfering apoptosis results in chemoresistance and poor prognosis of ovarian serous carcinoma patients.
Topics: Antineoplastic Agents; Apoptosis; Biomarkers, Tumor; Carcinoma, Ovarian Epithelial; Cell Line, Tumor; Cisplatin; Cytoskeletal Proteins; Drug Resistance, Neoplasm; Epigenomics; Female; Gene Silencing; Humans; Methylation; Neoplasms, Glandular and Epithelial; Ovarian Neoplasms; Paclitaxel; Prognosis; RNA, Small Interfering; Tumor Suppressor Proteins | 2013 |
New cytotoxic bis 5-alkylresorcinol derivatives from the leaves of Oncostemon bojerianum from the Madagascar rainforest.
Topics: Acetylation; Antineoplastic Agents, Phytogenic; Drug Screening Assays, Antitumor; Female; Humans; Inhibitory Concentration 50; Madagascar; Methylation; Molecular Conformation; Molecular Structure; Nuclear Magnetic Resonance, Biomolecular; Ovarian Neoplasms; Plant Leaves; Plants, Medicinal; Primulaceae; Resorcinols; Stereoisomerism; Tumor Cells, Cultured | 2002 |
Altered expression of the septin gene, SEPT9, in ovarian neoplasia.
Topics: Adult; Azacitidine; Base Sequence; Cell Line, Tumor; DNA, Circular; Female; Fetus; Gene Expression Regulation, Neoplastic; GTP Phosphohydrolases; Humans; Methylation; Mutation; Ovarian Neoplasms; Protein Splicing; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; RNA, Neoplasm; Septins; Transcription, Genetic | 2003 |
Significance of beta-catenin and pRB pathway components in malignant ovarian germ cell tumours: INK4A promoter CpG island methylation is associated with cell proliferation.
Topics: Adolescent; Adult; beta Catenin; Cell Cycle Proteins; Cell Transformation, Neoplastic; Child; Child, Preschool; CpG Islands; Cyclin D1; Cyclin-Dependent Kinase Inhibitor p16; Cytoskeletal Proteins; DNA, Neoplasm; Female; Genes, p16; Germinoma; Humans; Immunohistochemistry; In Situ Hybridization, Fluorescence; Methylation; Mutation; Neoplasm Proteins; Ovarian Neoplasms; Polymerase Chain Reaction; Promoter Regions, Genetic; Trans-Activators | 2004 |
An EGF receptor inhibitor induces RAR-beta expression in breast and ovarian cancer cells.
Topics: Breast Neoplasms; Cell Line, Tumor; Cell Proliferation; Enzyme Activation; ErbB Receptors; Female; Gene Expression Regulation; Gene Expression Regulation, Neoplastic; Humans; Methylation; Ovarian Neoplasms; Promoter Regions, Genetic; Quinazolines; Receptor, ErbB-2; Receptors, Retinoic Acid; RNA, Messenger | 2005 |
G3139 and other CpG-containing immunostimulatory phosphorothioate oligodeoxynucleotides are potent suppressors of the growth of human tumor xenografts in nude mice.
Topics: Adenocarcinoma; Adjuvants, Immunologic; Animals; Antineoplastic Agents; B-Lymphocytes; Carcinoma; Cell Line, Tumor; Cytosine; Female; Humans; Lung Neoplasms; Lymphocyte Activation; Methylation; Mice; Mice, Nude; Neoplasms; Oligodeoxyribonucleotides; Ovarian Neoplasms; Proto-Oncogene Proteins c-bcl-2; Thionucleotides; Xenograft Model Antitumor Assays | 2006 |
Histone modifications silence the GATA transcription factor genes in ovarian cancer.
Topics: Acetylation; Adaptor Proteins, Signal Transducing; Apoptosis Regulatory Proteins; Carcinoma; Cell Line, Tumor; Female; GATA Transcription Factors; GATA4 Transcription Factor; GATA6 Transcription Factor; Gene Silencing; Genes, Tumor Suppressor; Heterochromatin; Histones; Humans; Lysine; Methylation; Ovarian Neoplasms; Tumor Suppressor Proteins | 2006 |
Hypermethylation at a chromosome 17 "hot spot" is a common event in ovarian cancer.
Topics: Calcitonin; Chromosomes, Human, Pair 17; Female; Humans; Methylation; Ovarian Neoplasms | 1995 |
Genomic imprinting--defusing the ovarian time bomb.
Topics: Alleles; Animals; Choriocarcinoma; Embryonic and Fetal Development; Female; Gene Expression Regulation; Humans; Male; Mammals; Methylation; Mice; Models, Biological; Oocytes; Ovarian Neoplasms; Parents; Parthenogenesis; Phenotype; Pregnancy; Selection, Genetic; Teratoma; Testicular Neoplasms; Trophoblastic Neoplasms; Uterine Neoplasms | 1994 |
Advanced ovarian carcinoma: molecular evidence of unifocal origin.
Topics: Adult; Aged; Alleles; Chromosome Deletion; Cystadenocarcinoma, Papillary; DNA; Dosage Compensation, Genetic; Female; Heterozygote; Humans; Methylation; Middle Aged; Ovarian Neoplasms | 1993 |
[Methylation of DNA in tissue of ovarian malignant tumors in women].
Topics: Adult; Carcinoma; DNA, Neoplasm; Female; Humans; Methylation; Middle Aged; Ovarian Neoplasms; Sertoli Cell Tumor | 1993 |
Imprinting of human H19: allele-specific CpG methylation, loss of the active allele in Wilms tumor, and potential for somatic allele switching.
Topics: Adult; Alleles; Base Sequence; Chromosomes, Human, Pair 11; Dinucleoside Phosphates; DNA, Neoplasm; Female; Fetus; Humans; Methylation; Molecular Sequence Data; Ovarian Neoplasms; Promoter Regions, Genetic; Teratoma; Wilms Tumor | 1993 |
DNA methylation patterns in human tissues of uniparental origin using a zinc-finger gene (ZNF127) from the Angelman/Prader-Willi region.
Topics: Angelman Syndrome; DNA; Female; Genomic Imprinting; Humans; Hydatidiform Mole; Kruppel-Like Transcription Factors; Methylation; Ovarian Neoplasms; Prader-Willi Syndrome; Pregnancy; Repressor Proteins; Restriction Mapping; Teratoma; Transgenes; Zinc Fingers | 1996 |
Regulation of human endogenous retrovirus-K Gag expression in teratocarcinoma cell lines and human tumours.
Topics: Azacitidine; Butyrates; Butyric Acid; DNA Methylation; DNA, Viral; Female; Gene Products, gag; Humans; Male; Methylation; Ovarian Neoplasms; Retroelements; Teratocarcinoma; Testicular Neoplasms; Tumor Cells, Cultured | 1996 |
Homocysteine accumulation in human ovarian carcinoma ascitic/cystic fluids possibly caused by metabolic alteration of the methionine cycle in ovarian carcinoma cells.
Topics: Adult; Aged; Ascitic Fluid; Cysteine; Female; Folic Acid; Glycine; Homocysteine; Humans; Methionine; Methylation; Middle Aged; Ovarian Neoplasms; Vitamin B 12 | 1997 |
Association between nonrandom X-chromosome inactivation and BRCA1 mutation in germline DNA of patients with ovarian cancer.
Topics: Case-Control Studies; DNA, Neoplasm; Dosage Compensation, Genetic; Evolution, Molecular; Female; Genes, BRCA1; Germ-Line Mutation; Humans; Loss of Heterozygosity; Methylation; Ovarian Neoplasms | 1999 |
Re: Association between nonrandom X-chromosome inactivation and BRCA1 mutation in germline DNA of patients with ovarian cancer.
Topics: Age Factors; DNA, Neoplasm; Dosage Compensation, Genetic; Female; Genes, BRCA1; Germ-Line Mutation; Humans; Methylation; Ovarian Neoplasms; X Chromosome | 1999 |
BRCA1 and E-cadherin promoter hypermethylation and gene inactivation in cancer-association or mechanism?
Topics: Breast Neoplasms; Cadherins; Female; Gene Expression Regulation, Neoplastic; Genes, BRCA1; Humans; Loss of Heterozygosity; Methylation; Mutation; Neoplasms; Ovarian Neoplasms; Promoter Regions, Genetic; Stomach Neoplasms | 2000 |
Promoter hypermethylation and BRCA1 inactivation in sporadic breast and ovarian tumors.
Topics: Breast Neoplasms; Carcinoma, Ductal, Breast; Female; Gene Expression Regulation, Neoplastic; Genes, BRCA1; Humans; Loss of Heterozygosity; Methylation; Ovarian Neoplasms; Promoter Regions, Genetic; Reverse Transcriptase Polymerase Chain Reaction; RNA; RNA, Neoplasm; Transplantation, Heterologous; Tumor Cells, Cultured | 2000 |
P73 gene expression in ovarian cancer tissues and cell lines.
Topics: Adenocarcinoma, Clear Cell; Adenocarcinoma, Mucinous; Alleles; Blotting, Western; Carcinoma, Endometrioid; CpG Islands; Cystadenocarcinoma, Mucinous; Cystadenocarcinoma, Serous; Cystadenoma, Serous; DNA Methylation; DNA-Binding Proteins; Exons; Female; Genes, Tumor Suppressor; Humans; Loss of Heterozygosity; Lymphocytes; Methylation; Nuclear Proteins; Ovarian Neoplasms; Ovary; Polymorphism, Genetic; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Tumor Cells, Cultured; Tumor Protein p73; Tumor Suppressor Proteins | 2000 |
Molecular evidence for the independent origin of extra-ovarian papillary serous tumors of low malignant potential.
Topics: Adenocarcinoma, Papillary; Adult; Aged; Aged, 80 and over; DNA Restriction Enzymes; DNA, Neoplasm; Female; Humans; Methylation; Middle Aged; Ovarian Neoplasms; Peritoneal Neoplasms; Polymerase Chain Reaction; Sex Chromosome Aberrations; Trinucleotide Repeat Expansion; X Chromosome | 2001 |
Caveolin-1 is down-regulated in human ovarian carcinoma and acts as a candidate tumor suppressor gene.
Topics: Carcinoma; Caveolin 1; Caveolins; Cell Survival; Down-Regulation; Female; Genes, Tumor Suppressor; Humans; Methylation; Oligonucleotide Array Sequence Analysis; Ovarian Neoplasms; Phosphorylation; Tumor Cells, Cultured | 2001 |
Reduced expression of intercellular adhesion molecule-1 in ovarian adenocarcinomas.
Topics: Adenocarcinoma; Antimetabolites, Antineoplastic; Azacitidine; DNA Primers; DNA, Neoplasm; Down-Regulation; Female; Gene Expression Regulation, Neoplastic; Humans; Intercellular Adhesion Molecule-1; Loss of Heterozygosity; Methylation; Oligonucleotide Array Sequence Analysis; Ovarian Neoplasms; Prognosis; RNA, Messenger; Survival Analysis; Tumor Cells, Cultured | 2001 |
Embryonal lactosaminoglycan. The structure of branched lactosaminoglycans with novel disialosyl (sialyl alpha 2----9 sialyl) terminals isolated from PA1 human embryonal carcinoma cells.
Topics: Amino Sugars; Carbohydrate Sequence; Cell Line; Chromatography, Affinity; Chromatography, Gel; Female; Humans; Mass Spectrometry; Methylation; Models, Molecular; Ovarian Neoplasms; Polysaccharides; Teratoma | 1985 |
Transfer RNA methylase and transfer RNA methylase-inhibitor activity in normal and malignant human ovarian tissue.
Topics: Animals; Carbon Radioisotopes; Female; Guanine; Humans; Methylation; Neoplasm Metastasis; Ovarian Neoplasms; Ovary; Rabbits; RNA, Transfer; tRNA Methyltransferases | 1973 |
Initiation of malignant transformation and the significance of changes in transfer RNA methylase enzymes.
Topics: Animals; Carcinogens; Cell Line; Cell Transformation, Neoplastic; Cricetinae; Culture Techniques; Female; Kidney; Kidney Neoplasms; Male; Methylation; Methyltransferases; Mice; Neoplasms; Ovarian Neoplasms; Ovary; Prostate; Prostatic Neoplasms; RNA, Transfer; Transferases | 1971 |